Stories are generated from ORTEX data and reviewed by the ORTEX team. How we publish
Ameriprise Financial reports Q3 results on October 28, three weeks away, and arrives at that date with a stock down 11% over the past month, a divided analyst community, and insider selling that has been running steadily through the summer.
The most telling tension this week is between two analyst actions filed on consecutive days. Evercore ISI raised its target to $632 on October 7, maintaining an In-Line rating. The very next day, BMO Capital cut its target from $560 to $520, also holding at Market Perform. Both firms are sitting on the fence, but they are moving in opposite directions. The mean Street target is $569, implying roughly 15% upside from the current $496.61 close. Morgan Stanley remains the lone formal bear with an Underweight rating and a $489 target, essentially in line with where the stock trades today. Jefferies sits at the bullish end at $645. Most of the Street is clustered in the neutral-to-positive range, having lifted targets after July's Q2 print before the market sold the stock off anyway. The bull case rests on Ameriprise's near-$1.2 trillion wealth management franchise and a capital return programme that directs roughly 80% of operating earnings to shareholders. Bears point to deteriorating flows in the Asset Management segment, a 3% sequential drop in brokerage cash balances to $36.9 billion, and pressure in Retirement and Protection from legacy insurance outflows.
Valuation has re-rated lower with the share price. The price-to-earnings multiple has contracted by roughly 1.4 points over the past 30 days to 9.8x, and price-to-book has come in by about 0.8 points to 5.4x. Both moves reflect the stock's 11% monthly decline rather than a change in earnings expectations. EV/EBITDA is near 5.7x. Factor scores show the stock ranks in the 77th percentile on EPS surprise, a sign the company has consistently beaten estimates, and in the 87th percentile on EV/EBIT, which places it among the cheaper names in its universe on that measure. Momentum is the drag: the 90-day EPS momentum score ranks at 74, but the 30-day reading has slipped to 43, consistent with the broader price weakness.
Short positioning is modest and does not add much to the story. Short interest has crept up 2.4% over the past week and 9% over the past month to about 2.9% of the free float, a low absolute level. Borrowing costs are negligible at 0.53%, and the lending pool is essentially untouched, with availability at over 7,000% of short interest. Nothing in the borrow market suggests any meaningful bearish conviction. Options positioning has shifted slightly more defensive over the past few weeks. The put/call ratio is at 0.52, above its 20-day average of 0.47, though still well below mid-range. The 52-week high is 1.65, so current options activity is closer to complacent than alarmed.
Insider activity has been more pointed. Net selling over the trailing 90 days totals roughly $29 million across around 54,000 shares, with the most recent filings dated August 10. The transactions are a mix of compensation-related exercises and outright open-market sales. The EVP for Marketing sold 2,400 shares at $558 in early August, and the President of the Wealth Management Advisor Group sold 3,200 shares at $540 in late July, neither under a 10b5-1 plan. Those were discretionary sales made when the stock was trading roughly 12% above today's price. The activity is not alarming in aggregate, but the pattern is consistent with insiders reducing exposure into what was then a higher valuation.
Among peers, LPL Financial stands out this week with a gain of nearly 8% over the past five days, the sharpest mover in AMP's correlation cluster. Raymond James and Charles Schwab both drifted lower on the week, each off around 0.3% and 2.3% respectively, keeping AMP's flat week (down 0.1%) roughly in the middle of the group. FDIC call report data for Ameriprise's insured bank charters shows net loans and leases have risen for nine consecutive quarters, up 72% year-on-year as of Q2 2026. That dataset has not yet been tested as a lead for the company's reported financials, so it is background colour rather than a read on what the October 28 print will show.
What to watch heading into the Q3 release is whether AUM flows have stabilised in the Asset Management segment and whether brokerage cash balances have reversed their sequential decline, the two metrics that appear most central to the current bearish pushback from the Street's more cautious voices.
See the live data behind this article on ORTEX.
Open AMP on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data and reviewed by the ORTEX team. Content is informational only and does not constitute investment advice.
